Natco Pharma has reported a 23.91% increase in its consolidated net profit at Rs 17 crore for the quarter ended December 31, 2011. The company had posted a net profit of Rs 13.72 crore in the same period of the last financial year.
The consolidated total income during the third quarter also went up by 22.89% to Rs 145.43 crore from Rs 118.34 crore in the year-ago period.
The board of directors also declared an interim dividend of Rs 3 per equity share of Rs 10 each for 2011-2012.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: